Our offices are now closed. If you have a life-threatening emergency or urgent clinical need, please hang up and dial 911 or go to your nearest emergency department. For non-urgent issues, please click here for our After-Hours Frequently Asked Questions. If you need to request a prescription refill, please contact your pharmacy directly. You may also call us at 704-372-7900 to leave a general voice message or reach our after-hours answering service.
For Detailed Pollen Info, Click Here

Pollen and Mold Levels

Pollen counts are updated daily from February 15 to November 15.

Last Updated:

View Detailed Pollen Info
  • Eleven CAAC physicians voted ‘Top Doctors’ for 2022 in Charlotte Magazine

    Posted on: August 24, 2022

    We are pleased to announce that 11 of our physicians have been selected as 2022 Top Doctors for asthma and allergy care. Each year Charlotte Magazine publishes its list of the top doctors in the Charlotte area as chosen by their peers. We are honored for this recognition....

    Read More
  • Carolina Asthma & Allergy Center Expands to Matthews, Adds Four Providers

    Posted on: February 24, 2021

    Carolina Asthma & Allergy Center announces the addition of three board-certified physicians and a registered dietician to its growing practice. The Charlotte area’s largest asthma and allergy group also is opening its newest location, in Matthews, on April 1. This expansion brings the group’s regional presence to 14...

    Read More
  • Is it Safe to get the Covid-19 Vaccine if I Have Allergies?

    Posted on: January 27, 2021

    A Statement from Carolina Asthma & Allergy Center: The board-certified allergy and immunology physicians at Carolina Asthma & Allergy Center are closely monitoring the evolving data regarding safety and efficacy of the Pfizer and Moderna mRNA COVID-19 vaccines being distributed in our community. We are committed to doing...

    Read More
  • NOTICE: Voluntary Recall of Unexpired Albuterol Sulfate Inhalation Aerosol from Perrigo

    Posted on: September 24, 2020

    All patients who utilize the albuterol sulfate inhalation aerosol manufactured by Catalent Pharma Solutions for Perrigo Pharmaceutical Company should be aware that all unexpired inhalers have been recalled by the US Food & Drug Administration (FDA). This recall is due to complaints that some units may not dispense...

    Read More
  • Importance of Continuing Allergy and Asthma Treatment

    Posted on: August 30, 2020

    During this COVID-19 pandemic, almost everything in our lives has ground to a halt.   Almost.   While a lot of things stopped or closed or changed, a few things didn't. Allergies didn't stop. Asthma didn't stop. And the board-certified asthma and allergy specialists at Carolina Asthma &...

    Read More
  • FDA Alerts Patients and Providers of EpiPen Auto-Injector Errors

    Posted on: March 25, 2020

    The US Food and Drug Administration (FDA) is alerting patients, caregivers and health care professionals that EpiPen 0.3 mg and EpiPen Jr 0.15 mg auto-injectors, and the authorized generic versions, may potentially have delayed injection or be prevented from properly injecting due to: Device failure from spontaneous activation...

    Read More
  • We Now Offer Telemedicine Visits to Established Patients

    Posted on: March 24, 2020

    We are pleased to share that we are now offering Telemedicine Visits for established patients so we can diagnose and help treat allergy, rhinitis and more from afar.. Give us a call, and we'll be happy to make you an appointment. 704.372.7900

    Read More
  • Screening Instructions for Patients Prior to Your Appointment

    Posted on: March 19, 2020

    All of our offices are currently operating under normal business hours.  If you have an appointment with one of our providers, we look forward to seeing you at that time. Per CDC guidelines, all patients and visitors must wear a face covering inside our offices. Thank you. We...

    Read More
  • FDA Issues Drug Safety Communication for Singulair (Montelukast)

    Posted on: March 16, 2020

    The safety of our patients is very important to us. We want to make you aware that the Food and Drug Administration (FDA) has issued a drug safety communication for Singulair (Montelukast) concerning the risk neuropsychiatric events. Singulair is commonly used to prevent asthma attacks and allergy symptoms....

    Read More
  • Coronavirus Update for Patients: What We’re Doing — And What You Should Do

    Posted on: March 9, 2020

    The health and wellness of Carolina Asthma & Allergy Center patients and staff is always our highest priority. Authorities at the Centers for Disease Control and Prevention (CDC) report that the general population is at low risk for serious complications from Coronavirus exposure. Many of our patients are...

    Read More


Contact Us